Invariant TCR-triggered protein kinase D activation mediates NKT cell development
Journal of Experimental Medicine · 2025
DOI: 10.1084/jem.20250541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Eri Ishikawa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Immunology, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan. Hauptthemen laut MEDLINE: Natural Killer T-Cells, Receptors, Antigen, T-Cell, Protein Kinase C. Die Arbeit nennt 61 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Tokushima University.
Abstract (Originalsprache)
Development of invariant natural killer T (iNKT) cells in the thymus requires cell–cell interaction through invariant TCR (iTCR) and CD1d, which induces expression of the transcription factor, promyelocytic leukemia zinc finger (PLZF). However, the signaling pathway linking iTCR and PLZF remains unclear. Here, we report that a serine/threonine kinase, protein kinase D (PKD), plays a pivotal role in iNKT cell development. In T cell–specific PKD-deficient (Prkd2/3∆CD4) mice, PLZF induction and iNKT cell generation were severely impaired, which were rescued by introduction of a PLZF transgene. We identified the transcription factor Ikaros as a substrate of PKD upon iTCR stimulation. Knock-in mice carrying a phosphorylation-defective mutant Ikaros (Ikzf1S267/275A) exhibited an impairment of iNKT cell development, whereas conventional T cells were normal. In iNKT cells, Ikaros binds to the upstream region of the PLZF gene to induce its transcription. Mutant mice lacking the Ikaros-binding site (Zbtb16∆IBS) generated fewer iNKT cells than WT mice. These results suggest that PKD links iTCRs to PLZF induction through Ikaros, thereby mediating iNKT cell development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Immunology, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan.
- Laboratory of Molecular Immunology, Immunology Frontier Research Center (IFReC), The University of Osaka, Suita, Japan.
- Division of Cell Signaling, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
- Genome Information Research Center, Research Institute for Microbial Diseases, The University of Osaka , Suita, Japan.
- Department of Genetics, Hyogo Medical University, Nishinomiya, Japan.
- Department of Immunology and Stem Cell Biology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
ORCID-Profile: Eri Ishikawa, Hidetaka Kosako, Daisuke Motooka, Mai Imasaka, Hiroshi Watarai, Masaki Ohmuraya, Sho Yamasaki
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- Tokushima University
- Kyushu University
Zitieren
APA
Ishikawa, E., Kosako, H., Motooka, D., Imasaka, M., Watarai, H., Ohmuraya, M., & Yamasaki, S. (2025). Invariant TCR-triggered protein kinase D activation mediates NKT cell development. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20250541
Vancouver
Ishikawa E, Kosako H, Motooka D, Imasaka M, Watarai H, Ohmuraya M, et al. Invariant TCR-triggered protein kinase D activation mediates NKT cell development. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20250541
BibTeX
@article{Ishikawa2025,
author = {Ishikawa, Eri and Kosako, Hidetaka and Motooka, Daisuke and Imasaka, Mai and Watarai, Hiroshi and Ohmuraya, Masaki and Yamasaki, Sho},
title = {Invariant TCR-triggered protein kinase D activation mediates NKT cell development},
journal = {Journal of Experimental Medicine},
year = {2025},
doi = {10.1084/jem.20250541}
}
EUVIMED